ACTINIUM PHARMACEUTICALS, INC. Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax of $27.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-07
- ACTINIUM PHARMACEUTICALS, INC. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2026-06-30 was $27.90M.
- ACTINIUM PHARMACEUTICALS, INC. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2025-06-30 was -$6.88M.
| Period end | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 3 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 6 month |
|---|---|---|
| 2026-06-30 | $27.90M 10-Q · filed 2026-08-07 | $22.38M 10-Q · filed 2026-08-07 |
| 2025-06-30 | -$6.88M 10-Q · filed 2026-08-07 | -$22.82M 10-Q · filed 2026-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |